Announcements Trials
Browse Landscape

Status

Completed 7Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Sezary Syndrome 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Papillomavirus Infections 1Ovarian Neoplasms 1Neuroblastoma 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Neutrophilic, Chronic 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

utomilumab 1infigratinib 1human papillomavirus vaccine, L1 type 16, 18 1fludarabine 1durvalumab 1Interleukin-2 1Immunoglobulin G 1Engerix-B 1Disulfides 1Data Collection 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Papillomavirus Infections × Data Collection × Clear all
NCT01290393 2018-07-26

Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada

GlaxoSmithKline

Terminated
2 enrolled

Abortion, Spontaneous, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡